MASS stock

Is 908 Devices Inc (MASS) overvalued? · rev $59.6M

908 Devices Inc (MASS) is a medical devices company listed on US.

This page asks whether 908 Devices Inc (MASS) looks expensive on cached numbers — not a short thesis.

Latest reported MASS revenue for 2024-12-31 was $59.6M. Net income was -$72.2M. Revenue was up 18.7% from 2023-12-31 to 2024-12-31. MASS currently screens at market cap $238.5M.

MASS currently screens at market cap $238.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next MASS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the MASS stock page for the full model, not this heading.

Not investment advice.

Full MASS analysis